Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Future Medicinal Chemistry|July 31, 2024
Dual-target EZH2 inhibitor: latest advances in medicinal chemistryLai Wei, Dan Mei, Sijia Hu, et al.Journal of Nanoscience and Nanotechnology|May 10, 2020
Diabetic Retinopathy Analysis-Effects of Nanoparticle-Based TriamcinoloneShufang Du, Hongwei Wang, Feng Jiang, et al.Future Medicinal Chemistry|August 5, 2025
Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspectiveXuan Guan, Shu Cheng, Yifei Yin, et al.Scientific Reports|July 2, 2025
Knowledge, attitude, and practice of orthodontic treatment among student patients preparing for or undergoing treatmentYaping Zhang, Liangmei Gu, Bingxue Du, et al.BMC Ophthalmology|February 5, 2020
Rapamycin prevents retinal neovascularization by downregulation of cyclin D1 in a mouse model of oxygen-induced retinopathyFeng Jiang, Ying Wang, Shufang Du, et al.Frontiers in Pharmacology|August 11, 2025
CXCR3 inhibitors for therapeutic interventions: current status and perspectivesRongrong Huo, Yu Jiang, Li Zhang, et al.Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|February 7, 2024
[Construction of the Framework of a Prediagnostic Risk Assessment System for Outpatient Dental Care]Yongle Shi, Shufang DU, Xingfeng Lu, et al.Frontiers in Immunology|January 19, 2024
Nanomedicine for cancer targeted therapy with autophagy regulationKetai He, Mingkun Chen, Jiao Liu, et al.Journal of Oral Rehabilitation|September 19, 2025
Bridging Knowledge and Preparedness: The Role of Education and Symptoms in Nurses' Competency for Temporomandibular Disorder CareWenjing Yang, Zejin Liu, Yi Liu, et al.Frontiers in Pharmacology|August 8, 2026
Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistryJing Wen, Fan Liu, Ling Zhang, et al.Pageof 3